Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,075 | 2 | 35 | N/A | N/A |
| Receivables | N/A | 735 | N/A | N/A | N/A |
| TOTAL | $8,119 | $748 | $51 | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 370 | 0 | 0 | 0 |
| TOTAL | $N/A | $370 | $N/A | $N/A | $N/A |
| Total Assets | $8,119 | $1,117 | $51 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 342 | 1,234 | 68 | 0 | 0 |
| Accrued Expenses | 237 | 777 | 500 | N/A | N/A |
| TOTAL | $578 | $2,011 | $568 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 7,577 | 7,077 | 0 | 0 |
| TOTAL | $N/A | $7,683 | $7,077 | $N/A | $N/A |
| Total Liabilities | $578 | $9,694 | $7,645 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,947 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | 0 | N/A | N/A |
| Retained earnings | -14,239 | -8,777 | -7,786 | N/A | N/A |
| TOTAL | $7,541 | $-8,576 | $-7,594 | $N/A | $N/A |
| Total Liabilities And Equity | $8,119 | $1,117 | $51 | $0 | $0 |